Dependence of cerebrospinal fluid Tau protein levels on apolipoprotein E4 allele frequency in patients with Alzheimer's disease

Neuroscience Letters

Volumn 225, Issue 3, 1997, Pages 213-215

  Golombowski, Sidonie ^a   Müller Spahn, Franz ^a   Romig, Helmut ^b   Mendla, Klaus ^b   Hock, Christoph ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

biological markers; dementia; neurodegeneration; risk factors

Indexed keywords

APOLIPOPROTEIN E; TAU PROTEIN;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; FEMALE; HUMAN; MALE; NERVE DEGENERATION; PRIORITY JOURNAL;

AGED; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; FEMALE; HUMANS; MALE; MIDDLE AGED; TAU PROTEINS;

EID: 0343471538     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00228-0     Document Type: Article

References (10)

1. Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, I.L. and Pericak-Vance, M.A., Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, 261 (1993) 921-923.
2. Folstein, M.F., Folstein, S.E. and Mc Hugh, P.R. Mini Mental State. A practical method for grading the cognitive state of patients for the clinician, J. Psychiat. Res., 12 (1975) 189-198.
3. Hock, C., Golombowski, S., Naser, W. and Müller-Spahn, F., Increased levels of Tau protein in cerebrospinal fluid of patients with Alzheimer's disease - correlation with cognitive impairment, Ann. Neurol., 37 (1995) 414-415.
4. Mandelkow, E.M. and Mandelkow, E., Tau as marker for Alzheimer's disease, Trends Biol. Sci., 18 (1993) 480-483.
5. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E.M., Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease, Neurology, 34 (1984) 939-944.
6. Rosler, N., Wichart, I. and Jellinger, K.A., Intra vitam lumbar cerebrospinal fluid and serum and postmortem ventricular immunoreactive apolipoprotein E inpatients with Alzheimer's disease, J. Neurol. Neurosurg. Psychiat., 60 (1996) 452-454.
7. Saunders, A.M., Strittmatter, W.J., Schmechel, D., St George-Hyslop, P.J., Pericak-Vance, M.A., Joo, S.H., Rosi, B.L., Gusella, J.F., Crapper-MacLachlan, D.R., Alberts, M.J., Hulette, C., Crain, B., Goldgaber, D. and Roses, A.D., Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease, Neurology, 43 (1993) 1467-1472.
8. Selkoe, D.J., Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease, Annu. Rev. Cell. Biol., 10 (1994) 373-403.
9. Strittmatter, W.J., Saunders, A.M., Goedert, M., Weisgraber, K.H., Dong, L.M., Jakes, R., Huang, D.Y., Pericak-Vance, M., Schmechel, D. and Roses, A.D., Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease, Proc. Natl. Acad. Sci. USA, 91 (1994) 11183-11186.
10. Vandermeeren, M., Mercken, M., Vanmechelen, E., Six, J., van de Voorde, A., Martin, J.J. and Cras, P., Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay, J. Neurochem., 61 (1993) 1828-1834.